Dr. Erica Schwartz, the new director of the Centers for Disease Control and Prevention (CDC), addressed employees in her initial staff meeting. She emphasized her commitment to advocating for the agency and recognized the staffing shortages and the burnout faced by employees.
Schwartz highlighted her willingness to privately voice any disagreements with U.S. Health Secretary Robert F. Kennedy Jr. Her focus remains on maintaining professionalism and discretion in handling such matters.
Having assumed her role last week, Schwartz addressed CDC staff in Atlanta. She acknowledged the existence of congressionally funded CDC programs that lack personnel due to layoffs during President Donald Trump’s tenure. These programs have been deemed inactive and are referred to as “zombie” programs.
Schwartz committed to understanding these issues through discussions with CDC staff, reinforcing confidence in her advocacy for the agency. Her previous experience in uniformed government roles, such as with the U.S. Coast Guard and Public Health Service, informs her leadership approach.
Her leadership marks the 22nd directorship of the CDC, an entity integral to safeguarding public health. She stressed the importance of rebuilding public trust through transparency, scientific rigor, and honest communication, principles also articulated by Kennedy.
The CDC has faced significant workforce reductions, losing over 3,000 employees, which equates to more than a quarter of the workforce. These challenges, alongside leadership changes and political appointees lacking public health expertise, have affected morale.
Kennedy’s actions, aligning with anti-vaccine sentiments and involving disbanding of expert committees, have impacted CDC strategies. Schwartz noted the initiation of a task force on childhood vaccine safety, tasked with reporting within 90 days.
Responses from CDC staff and former employees, including those from the National Public Health Coalition, reflect cautious optimism. They stress the need for a leader who prioritizes science and public safety over politics, with trust to be built through definitive actions.
Schwartz aims to fulfill these expectations and address the complex issues facing the CDC under her leadership.
Dr. Heidi Overton to Lead FDA Under Trump’s Nomination 
Guidance on Taking Oral GLP-1 Medications 
FDA Issues Highest Risk Warning for Recalled Berry Products Due to E. coli Contamination 
Study Finds High Levels of Plastic in Bottled Water and Suggests Safer Alternatives 
Workplace Violence Sparks Strikes by Healthcare Workers 
Escalating Ebola Crisis in Congo: Over 5,000 Cases Reported